SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-18-008757
Filing Date
2018-02-14
Accepted
2018-02-14 14:49:27
Documents
2
Group Members
THOMAS M. CLAY

Document Format Files

Seq Description Document Type Size
1 SC 13G tv486141_sc13g.htm SC 13G 73546
2 EXHIBIT 1 tv486141_ex-1.htm EX-99.1 3577
  Complete submission text file 0001144204-18-008757.txt   79000
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-31596 | Film No.: 18611223
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 MEMORIAL BOULEVARD SUITE 902 PROVIDENCE RI 02903
Business Address 10 MEMORIAL BOULEVARD SUITE 902 PROVIDENCE RI 02903 401-490-0700
East Hill Management Company, LLC (Filed by) CIK: 0001426610 (see all company filings)

IRS No.: 043523704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G